Nat Sims, MD, an anesthesiologist and device pioneer at Mass General analyzes the Food and Drug Administration’s fresh approach to monitoring medical devices suspected of falling short.
Mass General groups organized a rally then marched to Boston Common to help celebrate Boston as a place for scientists and scientific research.
Harry W. Orf, PhD, Mass General’s senior vice president for research, says the Trump Administration’s proposed cuts to medical research funding are cause for deep concern and will impact patients.
The pen is mightier than the scalpel when it comes to preventing injuries, says Peter Masiakos, MD, who leads the MGH Trauma Injury Prevention and Outreach Program.
Mass General President Peter L. Slavin, MD, says that, despite progress, a tremendous amount of work remains to be done to eradicate lingering racial disparities in health care.
Over the past decade, Massachusetts General Hospital has launched a variety of diversity initiatives to address disparities in care and employment.
Mass General molecular biologist Jack Szostak, PhD, says that, despite funding challenges, it is still a great time to be involved in science and research.
With federal funding for research uncertain, the scientific director of the MGH Research Institute discusses alternative ways to provide sustainable and rewarding careers for the next generation of scientists.
A Mass General addiction expert says one police department’s emphasis on treatment over arrest is an encouraging step in addressing the drug epidemic.
For ten years, the Disparities Solutions Center has been using Mass General’s successes in reducing health disparities to engage others nationally.